Td Waterhouse Canada Inc. Atai Life Sciences N.V. Transaction History
Td Waterhouse Canada Inc.
- $14.8 Trillion
- Q2 2024
A detailed history of Td Waterhouse Canada Inc. transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Td Waterhouse Canada Inc. holds 400 shares of ATAI stock, worth $512. This represents 0.0% of its overall portfolio holdings.
Number of Shares
400
Previous 400
-0.0%
Holding current value
$512
Previous $744,000
81.99%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ATAI
# of Institutions
98Shares Held
12.8MCall Options Held
9.2KPut Options Held
118K-
Walleye Capital LLC Plymouth, MN2.76MShares$3.54 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.72MShares$3.48 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$1.67 Million0.0% of portfolio
-
Brown University719KShares$919,6800.39% of portfolio
-
Two Sigma Investments, LP New York, NY717KShares$917,9270.0% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $212M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...